
Almac Group Ltd - Strategic SWOT Analysis Review
Description
Almac Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Almac Group Ltd (Almac) is a contract development and manufacturing organization. The company provides integrated services to pharmaceutical and biotechnology companies. The company offers its services across the lifecycle of biopharmaceutical products which extend from research through pharmaceutical and clinical development to the commercialization of products. Its services portfolio include diagnostics and biomarker development, clinical technologies, active pharmaceutical ingredient (API) services and chemical development, pharmaceutical development, analytical services, clinical services and commercial services. The company operates through its subsidiaries in California, North Carolina, and Pennsylvania in the US, and Singapore. Almac is headquartered in Craigavon, Northern Ireland, the UK.
Almac Group Ltd Key Recent Developments
Nov 07,2024: Almac’s Singapore Facility Secures GMP Certification
Oct 01,2024: Almac Group Announces £11m Investment to Expand Global Analytical Services
May 28,2024: Almac Group Announces Record Revenue Figure Resulting From Another Year of Growth
Mar 06,2024: Almac Group Expands Commercial Manufacturing and Packaging as well as Peptide Production Capacity
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Almac Group Ltd (Almac) is a contract development and manufacturing organization. The company provides integrated services to pharmaceutical and biotechnology companies. The company offers its services across the lifecycle of biopharmaceutical products which extend from research through pharmaceutical and clinical development to the commercialization of products. Its services portfolio include diagnostics and biomarker development, clinical technologies, active pharmaceutical ingredient (API) services and chemical development, pharmaceutical development, analytical services, clinical services and commercial services. The company operates through its subsidiaries in California, North Carolina, and Pennsylvania in the US, and Singapore. Almac is headquartered in Craigavon, Northern Ireland, the UK.
Almac Group Ltd Key Recent Developments
Nov 07,2024: Almac’s Singapore Facility Secures GMP Certification
Oct 01,2024: Almac Group Announces £11m Investment to Expand Global Analytical Services
May 28,2024: Almac Group Announces Record Revenue Figure Resulting From Another Year of Growth
Mar 06,2024: Almac Group Expands Commercial Manufacturing and Packaging as well as Peptide Production Capacity
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
36 Pages
- Section 1 - About the Company
- Almac Group Ltd - Key Facts
- Almac Group Ltd - Key Employees
- Almac Group Ltd - Key Employee Biographies
- Almac Group Ltd - Major Products and Services
- Almac Group Ltd - History
- Almac Group Ltd - Company Statement
- Almac Group Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Almac Group Ltd - Business Description
- Almac Group Ltd - SWOT Analysis
- SWOT Analysis - Overview
- Almac Group Ltd - Strengths
- Almac Group Ltd - Weaknesses
- Almac Group Ltd - Opportunities
- Almac Group Ltd - Threats
- Almac Group Ltd - Key Competitors
- Section 3 – Company’s Lifesciences Financial Deals and Alliances
- Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
- Almac Group Ltd, Recent Deals Summary
- Section 4 – Company’s Recent Developments
- Nov 07, 2024: Almac’s Singapore Facility Secures GMP Certification
- Oct 01, 2024: Almac Group Announces £11m Investment to Expand Global Analytical Services
- May 28, 2024: Almac Group Announces Record Revenue Figure Resulting From Another Year of Growth
- Mar 06, 2024: Almac Group Expands Commercial Manufacturing and Packaging as well as Peptide Production Capacity
- Feb 06, 2024: Almac Group Signs Virtual Power Purchase Agreement (Vppa) for Renewable Energy Reducing Their Global Scope 2 Emissions by 46%
- Jan 25, 2024: Almac Sciences Extends selectAZyme Offering to Include Therapeutic Oligonucleotide Synthesis
- Section 5 – Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Almac Group Ltd, Key Facts
- Almac Group Ltd, Key Employees
- Almac Group Ltd, Key Employee Biographies
- Almac Group Ltd, Major Products and Services
- Almac Group Ltd, History
- Almac Group Ltd, Other Locations
- Almac Group Ltd, Subsidiaries
- Almac Group Ltd, Key Competitors
- Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
- Almac Group Ltd, Recent Deals Summary
- List of Figures
- Almac Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Almac Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.